New Catheter-Based valve offers hope for High-Risk heart patients

NCT ID NCT03339115

First seen Jan 08, 2026 · Last updated May 17, 2026 · Updated 18 times

Summary

This study tests a new device that fixes a severe leaky heart valve (mitral regurgitation) without open-heart surgery. It is for 30 people who are too high-risk for traditional surgery. The device is threaded through a vein in the leg to the heart, and the study will check if it is safe and works well over two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • A.O.U. Pisana

    Pisa, 56126, Italy

  • Fondazione Toscana G. Monasterio-Ospedale del Cuore

    Massa, 54100, Italy

  • Herzzentrum der Uniklinik Köln

    Cologne, Germany

  • Hygea

    Athens, Greece

  • Klinikum der Universität München LMU

    München, Germany

  • Maria Cecilia Hospital

    Cotignola, Italy

  • Policlinico San Donato

    Milan, Italy

  • San Raffaele Hospital

    Milan, 20129, Italy

  • Studienzentrale der Medizinische Klinik II Universitäres Herzzentrum Lübeck

    Lübeck, Germany

  • Universitaet_Mainz

    Mainz, Germany

  • Universitätsklinikum Bonn

    Bonn, North Rhine-Westphalia, 53127, Germany

Conditions

Explore the condition pages connected to this study.